About this trial
This randomized controlled trial will examine the effects of mindfulness-based interventions and brain stimulation interventions on cognitive function and psychological well-being in older adults. The study will employ a comprehensive assessment approach incorporating psychological evaluations, behavioral assessments, psychophysiological measurements, and neuroimaging analyses to characterize the outcome of nonpharmaceutical interventions in improving geriatric well-being or reducing depression severity.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Literate or have received an education above the elementary level.
Have normal or corrected vision and hearing, able to communicate and understand explanations.
Right-handed individuals as assessed by the Edinburgh Handedness Inventory.
Disqualifiers
Individuals with dementia, stroke, cerebrovascular disease, brain injury, epilepsy, or Parkinson's disease.
Individuals with neurological system disorders.
Individuals with alcohol or drug dependence.
Individuals with other major physical illnesses, such as diabetes, heart failure, or endocrine abnormalities, or those who have experienced an acute myocardial infarction within the past three months.
Trial design
Parallel
Treatments tested in this trial
MBSR
BehavioralMindfulness-Based Stress Reduction
MBWC
BehavioralMindfulness-Based Well-Being Curriculum
MBCI
BehavioralMindfulness-Based Curriculum for Insomnia
BSI
DeviceBrain Stimulation Intervention
Treatment groups
Trial outcomes
Primary outcomes
Changes in neural activation related to emotional processing, sensory processing, attention, and memory-related brain regions.
Significant alterations in blood oxygen level-dependent (BOLD) signal amplitude during task-based functional magnetic resonance imaging (fMRI).
Changes in resting-state functional connectivity within and between brain networks
Statistically significant alterations in intrinsic functional connectivity parameters derived from blood-oxygen-level-dependent (BOLD) signals acquired during resting-state functional magnetic resonance imaging (rs-fMRI).
Secondary outcomes
Regional brain morphometric changes, assessed by quantitative analysis of gray matter volume, thickness, and density differences using high-resolution structural magnetic resonance imaging.
Statistically significant alterations in regional gray matter volume (measured in cubic millimeters), thickness (measured in millimeters) or density (represented as a percentage between 0 and 1) compared to baseline measurements.
Self-reported neuropsychological outcomes assessed through validated Wechsler Adult Intelligence Scale (WAIS).
Statistically significant changes across 3 time points using WAIS across subsets of facial memory test and (scores between 0 and 48), digit span in forward (scores between 0 and 16) and backward order (scores between 0 and 14), block design (scores between 0 and 68), digit symbol-coding (scores between 0 and 133).
Scores of the total number of category-naming items correctly named within one minute for testing verbal fluency.
Statistically significant changes across 3 time points using Verbal fluency scores in categories of colors, animals, cities, and fruits.
Changes in the depression scale
Depression scale changes measured by the geriatric depression scale (scores between 0 and 15) and the 17-item Hamilton depression rating scale (scores between 0 and 52) across 3 time points.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.